Tonix Pharmaceuticals Holding Corp.Mis à jour "Balanced Biotech Strategy"
Trading TNXP requires careful consideration of both the high reward potential and the significant risks involved. Combining technical analysis for short-term trades with a fundamental approach for long-term investments, while employing robust risk management techniques, can help navigate the volatile nature of this stock. Always stay informed about the latest company developments and market conditions to make well-informed decisions.
Transaction en cours
Note
I started investing in this stock before its split in January 2023, with a consistent accumulation strategy that brought my average cost to 16 cents. Leveraging thorough technical analysis, extensive research, and a personal connection to the company, I identified its long-term potential early on.
Recently, I took profits at $1.90 while maintaining a core position for the long term. This approach balances steady growth with strategic profit-taking, reflecting my confidence in the company's trajectory.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.